WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Sale |
2024-12-31 | 13G | Myriad Genetics, Inc. MYGN |
WELLINGTON MANAGEMENT CO LLP | 6,004,598 6.600% |
-1,215,108 (-16.83%) |
Filing |
| 2024-02-08 10:14 am Purchase |
2023-12-29 | 13G | Myriad Genetics, Inc. MYGN |
WELLINGTON MANAGEMENT CO LLP | 7,219,706 8.070% |
432,483 (+6.37%) |
Filing |
| 2023-02-06 2:53 pm Purchase |
2022-12-30 | 13G | Myriad Genetics, Inc. MYGN |
WELLINGTON MANAGEMENT CO LLP | 6,787,223 8.380% |
2,461,448 (+56.90%) |
Filing |
| 2022-02-04 09:21 am Purchase |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
WELLINGTON MANAGEMENT CO LLP | 4,325,775 5.420% |
952,575 (+28.24%) |
Filing |